Around one in three stroke patients suffers a relapse - often just a few days after the initial cerebral infarction. Doctors at TU Dresden are now starting a large nationwide study with 2,100 participants. They want to find out whether a combination of two drugs provides better protection against a second stroke than the current standard therapy. The Federal Ministry of Research is funding the project with three million euros.
